LEADER 02677nam  2200637 a 450 
001 9910457701403321
005 20200520144314.0
010   $a1-283-25354-2
010   $a9786613253545
010   $a0-309-21491-2
035   $a(CKB)2550000000051836
035   $a(EBL)3378855
035   $a(SSID)ssj0000533788
035   $a(PQKBManifestationID)11319018
035   $a(PQKBTitleCode)TC0000533788
035   $a(PQKBWorkID)10504138
035   $a(PQKB)10851009
035   $a(MiAaPQ)EBC3378855
035   $a(Au-PeEL)EBL3378855
035   $a(CaPaEBR)ebr10495455
035   $a(CaONFJC)MIL325354
035   $a(OCoLC)923284117
035   $a(EXLCZ)992550000000051836
100   $a20111003d2011      uy             0
101 0 $aeng
135   $auruz#---auuu|
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAdvancing regulatory science for medical countermeasure development$b[electronic resource] $eworkshop summary /$fTheresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, rapporteurs
210   $aWashington, D.C. $cNational Academies Press$d2011
215   $a1 online resource (150 pages)
300   $aDescription based upon print version of record.
311   $a0-309-21490-4 
320   $aIncludes bibliographical references.
327   $a""Front Matter""; ""Reviewers""; ""Contents""; ""Tables, Figures, and Boxes""; ""Acronyms""; ""1 Introduction""; ""2 MCM Enterprise and Stakeholder Perspectives""; ""3 Cutting-Edge Efforts to Advance MCM Regulatory Science""; ""4 MCM Regulatory Science Needs for At-Risk Populations""; ""5 Crosscutting Themes and Future Directions""; ""6 Closing Remarks""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: Participant Biographies""
606   $aEmergency management$zUnited States$xEvaluation$vCongresses
606   $aDisaster medicine$zUnited States$xEvaluation$vCongresses
606   $aWeapons of mass destruction$xHealth aspects$vCongresses
606   $aChemical agents (Munitions)$vCongresses
608   $aElectronic books.
615  0$aEmergency management$xEvaluation
615  0$aDisaster medicine$xEvaluation
615  0$aWeapons of mass destruction$xHealth aspects
615  0$aChemical agents (Munitions)
676   $a616.0250973
701   $aWizemann$b Theresa M$0890630
701   $aAltevogt$b Bruce M$0856949
701   $aClaiborne$b Anne B$0897033
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910457701403321
996   $aAdvancing regulatory science for medical countermeasure development$92486771
997   $aUNINA